Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$2.68
-1.65%today
MKT CAP
$520M
+34.7% · 1Y
Earnings History
-50.0%
+100.0%
-100.0%
+71.4%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$2.68
Low
$4.00
Analyst Mean
$4.67
High
$5.00
3 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-334.5x
Price/Sales-
Dividend Yield-
Revenue Growth YoY+24.1%
Earnings Growth YoY-
Revenue Growth QoQ-7.1%
5y Revenue CAGR+8.4%
5y Earnings CAGR-
Gross Margin53.0%
Operating Margin-0.7%
Net Margin-4.4%
ROE-15.4%
Debt / Equity142.57x
Free Cash Flow$2M
Insider Ownership3.2%
Institutional Ownership75.1%
Short % of Float5.76%
Days to Cover8.1d
1 Week+38.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| JAYARAMAN VIVEK K. MBA | Chief Operating Officer | Sale | 16,667 | $3.00 | $0.05M | 2026-05-01 |
| GREEN KEVIN DENNIS | Chief Financial Officer | Stock | 200,000 | $0.00 | $0.00M | 2026-04-01 |
| JENSEN CHRYSTAL MENARD | Officer | Stock | 200,000 | $0.00 | $0.00M | 2026-04-01 |
| GREEN KEVIN DENNIS | Chief Financial Officer | Sale | 127,544 | $1.66 | $0.21M | 2026-03-12 |
| JAYARAMAN VIVEK K. MBA | Chief Operating Officer | Sale | 165,200 | $1.66 | $0.27M | 2026-03-12 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Blackrock Inc. | institution | 10.94% | $0.06B | +4.47% | 2025-12-31 |
| ARK Investment Management, LLC | institution | 9.08% | $0.05B | -3.45% | 2025-12-31 |
| Vanguard Group Inc | institution | 5.57% | $0.03B | +3.52% | 2025-12-31 |
| Baker Bros. Advisors, LP | institution | 4.99% | $0.03B | +0.00% | 2025-12-31 |
| ARK ETF Trust-ARK Innovation ETF | fund | 4.81% | $0.03B | +0.55% | 2026-04-30 |
| ARK ETF Trust-ARK Genomic Revolution ETF | fund | 3.72% | $0.02B | +16.35% | 2026-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.86% | $0.01B | +3.40% | 2025-12-31 |
| Wasatch Advisors LP | institution | 2.64% | $0.01B | -3.32% | 2026-03-31 |
| WASATCH FUNDS TRUST-Wasatch Ultra Growth Fund | fund | 2.58% | $0.01B | -3.49% | 2026-03-31 |
| Silvercrest Asset Management Group, LLC | institution | 2.34% | $0.01B | +13.63% | 2025-12-31 |
| Sumitomo Mitsui Trust Group, Inc. | institution | 2.25% | $0.01B | -4.11% | 2026-03-31 |
| Amova Asset Management Americas Inc | institution | 2.25% | $0.01B | -4.11% | 2026-03-31 |
| Geode Capital Management, LLC | institution | 2.24% | $0.01B | -0.72% | 2025-12-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 2.24% | $0.01B | +0.68% | 2026-03-31 |
| Soleus Capital Management, L.P. | institution | 2.00% | $0.01B | +100.00% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 1.06% | $0.01B | +1.61% | 2025-12-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.90% | $0.00B | +0.71% | 2026-02-28 |
| BlackRock Funds-BlackRock Advantage Small Cap Core Fund | fund | 0.77% | $0.00B | -2.32% | 2026-02-28 |
| iShares Trust-iShares Russell 2000 Growth ETF | fund | 0.75% | $0.00B | -1.15% | 2026-03-31 |
| Fidelity Covington Trust-Fidelity Enhanced Small Cap ETF | fund | 0.52% | $0.00B | +3.80% | 2026-04-30 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| AVNS | $1.2B | 60 | - | 19.8 | 22.1 | -9.2% | 50% | 17.70 | 0.00% |
| BFLY | $1.2B | - | - | - | - | - | - | - | 0.00% |
| TNDM | $1.2B | - | - | - | - | - | - | - | 0.00% |
| INSP | $1.3B | 56 | 10.9 | 34.6 | - | - | - | - | 0.00% |
| PRCT | $1.4B | 5 | - | - | - | - | - | - | 0.00% |
| ENOV | $1.4B | 100 | - | 6.0 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for CERS.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.